Overview

Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Rosacea Patients

Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Acne rosacea is a chronic acneiform disorder affecting both the skin and the eye. It is a syndrome of undetermined etiology characterized by both vascular and papulopustular components involving the face and occasionally the neck and upper trunk. This is a pilot phase II study to evaluate the tolerability and safety and to monitor the clinical efficacy of Topical Minocycline Foam FXFM244 in moderate to severe Rosacea patients.
Phase:
Phase 2
Details
Lead Sponsor:
Foamix Ltd.
Vyne Therapeutics Inc.
Treatments:
Minocycline